Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Zhou KI, Lin C, Tseng CL, Ramnath N, Dowell JE, Kelley MJ. Brief Report: Real-World Efficacy and Safety of Sotorasib in U.S. Veterans with KRAS G12C-Mutated NSCLC. JTO Clin Res Rep. 2024 May;5(5):100670. doi: 10.1016/j.jtocrr.2024.100670. eCollection 2024 May. PubMed PMID: 38746048; PubMed Central PMCID: PMC11090863.
Lichtenstein MRL, Levit LA, Schenkel C, Kirkwood K, Fashoyin-Aje LA, Bruinooge SS, Kelley MJ, Mailman JA, Magnuson A, Mirda DP, Natesan D, Hershman DL. Researcher Experience and Comfort With Telemedicine and Remote Patient Monitoring in Cancer Treatment Trials. Oncologist. 2024 Apr 4;29(4):356-363. doi: 10.1093/oncolo/oyad237. PubMed PMID: 37676048; PubMed Central PMCID: PMC10994398.
Patel JN, Jiang C, Owzar K, Hertz DL, Wang J, Mulkey FA, Kelly WK, Halabi S, Furukawa Y, Lassiter C, Dorsey SG, Friedman PN, Small EJ, Carducci MA, Kelley MJ, Nakamura Y, Kubo M, Ratain MJ, Morris MJ, McLeod HL. Pharmacogenetic and clinical risk factors for bevacizumab-related gastrointestinal hemorrhage in prostate cancer patients treated on CALGB 90401 (Alliance). Pharmacogenomics J. 2024 Mar 4;24(2):6. doi: 10.1038/s41397-024-00328-z. PubMed PMID: 38438359; PubMed Central PMCID: PMC10912014.
Justice AC, Tate JP, Howland F, Gaziano JM, Kelley MJ, McMahon B, Haiman C, Wadia R, Madduri R, Danciu I, Leppert JT, Leapman MS, Thurtle D, Gnanapragasam VJ. Adaption and National Validation of a Tool for Predicting Mortality from Other Causes Among Men with Nonmetastatic Prostate Cancer. Eur Urol Oncol. 2024 Jan 2;. doi: 10.1016/j.euo.2023.11.023. [Epub ahead of print] PubMed PMID: 38171965.
Zhou KI, Kelley MJ. Reply to M.S. Brose et al. JCO Precis Oncol. 2023 Sep;7:e2300275. doi: 10.1200/PO.23.00275. PubMed PMID: 37769222; PubMed Central PMCID: PMC10581632.
Scobie MR, Zhou KI, Ahmed S, Kelley MJ. Utility of Tumor Mutational Burden as a Biomarker for Response to Immune Checkpoint Inhibition in the VA Population. JCO Precis Oncol. 2023 Sep;7:e2300176. doi: 10.1200/PO.23.00176. PubMed PMID: 38039430.
Shevach JW, Aiello LB, Lynch JA, Petersen J, Hoffman-Hogg L, Hartzfeld D, Lundquist M, Kelley MJ, Scheuner MT, Montgomery R, Damjanov N, Robinson K, Wong YN, Jhala D, Parikh RB, Maxwell KN. On-Site Nurse-Led Cancer Genetics Program Increases Cancer Genetic Testing Completion in Black Veterans. JCO Oncol Pract. 2023 Aug;19(8):637-644. doi: 10.1200/OP.22.00738. Epub 2023 May 23. PubMed PMID: 37220320; PubMed Central PMCID: PMC10424905.
Bates JS, Piccolo J, Crandall B, Kelley MJ. Oncology Pharmacists Help Bridge the Gap to Optimize Precision Oncology Services for Veterans With Cancer. JCO Oncol Pract. 2023 Aug;19(8):676-677. doi: 10.1200/OP.23.00220. Epub 2023 Jun 30. PubMed PMID: 37390385.
Bryant AK, Chopra Z, Edwards DM, Whalley AS, Bazzell BG, Moeller JA, Kelley MJ, Fendrick AM, Kerr EA, Ramnath N, Green MD, Hofer TP, Strohbehn GW. Adopting Weight-Based Dosing With Pharmacy-Level Stewardship Strategies Could Reduce Cancer Drug Spending By Millions. Health Aff (Millwood). 2023 Jul;42(7):946-955. doi: 10.1377/hlthaff.2023.00102. PubMed PMID: 37406228; PubMed Central PMCID: PMC10985582.
Valle LF, Nickols NG, Hausler R, Alba PR, Anglin-Foote T, Perez C, Yamoah K, Rose BS, Kelley MJ, DuVall SL, Garraway IP, Maxwell KN, Lynch JA. Actionable Genomic Alterations in Prostate Cancer Among Black and White United States Veterans. Oncologist. 2023 Jun 2;28(6):e473-e477. doi: 10.1093/oncolo/oyad042. PubMed PMID: 37084789; PubMed Central PMCID: PMC10243786.
Zullig LL, Raska W, McWhirter G, Sherman SE, Makarov D, Becker D, King HA, Pura J, Jeffreys AS, Danus S, Passero V, Goldstein KM, Kelley MJ. Veterans Health Administration National TeleOncology Service. JCO Oncol Pract. 2023 Apr;19(4):e504-e510. doi: 10.1200/OP.22.00455. Epub 2023 Jan 17. PubMed PMID: 36649579; PubMed Central PMCID: PMC10113113.
Zhou KI, Vashistha V, Guo A, Ahmed S, Kelley MJ. Real-world Experience With Neurotrophic Tyrosine Receptor Kinase Fusion-positive Tumors and Tropomyosin Receptor Kinase Inhibitors in Veterans. JCO Precis Oncol. 2023 Mar;7:e2200692. doi: 10.1200/PO.22.00692. PubMed PMID: 36926986.
Williams CD, Allo MA, Gu L, Vashistha V, Press A, Kelley M. Health outcomes and healthcare resource utilization among Veterans with stage IV non-small cell lung cancer treated with second-line chemotherapy versus immunotherapy. PLoS One. 2023;18(2):e0282020. doi: 10.1371/journal.pone.0282020. eCollection 2023. PubMed PMID: 36809528; PubMed Central PMCID: PMC9942992.
Dent KR, Szymanski BR, Kelley MJ, Katz IR, McCarthy JF. Suicide risk following a new cancer diagnosis among Veterans in Veterans Health Administration care. Cancer Med. 2023 Feb;12(3):3520-3531. doi: 10.1002/cam4.5146. Epub 2022 Aug 27. PubMed PMID: 36029038; PubMed Central PMCID: PMC9939100.
Vashistha V, Katsoulakis E, Guo A, Price M, Ahmed S, Kelley MJ. Molecular-Guided Off-Label Targeted Therapy in a Large-Scale Precision Oncology Program. JCO Precis Oncol. 2023 Feb;7:e2200518. doi: 10.1200/PO.22.00518. PubMed PMID: 36787508; PubMed Central PMCID: PMC10309545.
Scheuner MT, Sales P, Hoggatt K, Zhang N, Whooley MA, Kelley MJ. Genetics professionals are key to the integration of genetic testing within the practice of frontline clinicians. Genet Med. 2023 Jan;25(1):103-114. doi: 10.1016/j.gim.2022.09.012. Epub 2022 Oct 28. PubMed PMID: 36301261.
Doerstling S, Winski D, Katsoulakis E, Agarwal P, Poonnen PJ, Snowdon JL, Jackson GP, Weeraratne D, Kelley MJ, Vashistha V. Mutational profiles of head and neck squamous cell carcinomas based upon human papillomavirus status in the Veterans Affairs National Precision Oncology Program. J Cancer Res Clin Oncol. 2023 Jan;149(1):69-77. doi: 10.1007/s00432-022-04358-7. Epub 2022 Sep 18. PubMed PMID: 36117189.
Strohbehn GW, Holleman R, Burns J, Klamerus ML, Kelley MJ, Kerr EA, Ramnath N, Hofer TP. Adoption of Extended-Interval Dosing of Single-Agent Pembrolizumab and Comparative Effectiveness vs Standard Dosing in Time-to-Treatment Discontinuation. JAMA Oncol. 2022 Nov 1;8(11):1663-1667. doi: 10.1001/jamaoncol.2022.4109. PubMed PMID: 36136314; PubMed Central PMCID: PMC9501784.
Shuman AG, Aapro MS, Anderson B, Arbour K, Barata PC, Bardia A, Bruera E, Chabner BA, Chen H, Choy E, Conte P, Curigliano G, Dizon D, O'Reilly E, Tito Fojo A, Gelderblom H, Graubert TA, Gurtler JS, Hall E, Hirsch FR, Idbaih A, Ilson DH, Kelley M, La Vecchia C, Ludwig H, Moy B, Muss H, Opdam F, Pentz RD, Posner MR, Ross JS, Sacher A, Senan S, Perez de Celis ES, Tanabe KK, Vermorken JB, Wehrenberg-Klee E, Bates SE. Supporting Patients with Cancer after Dobbs v. Jackson Women's Health Organization. Oncologist. 2022 Aug 13;27(9):711-3. doi: 10.1093/oncolo/oyac165. [Epub ahead of print] PubMed PMID: 35962750; PubMed Central PMCID: PMC9438903.
Bryant AK, Sankar K, Zhao L, Strohbehn GW, Elliott D, Moghanaki D, Kelley MJ, Ramnath N, Green MD. De-escalating adjuvant durvalumab treatment duration in stage III non-small cell lung cancer. Eur J Cancer. 2022 Aug;171:55-63. doi: 10.1016/j.ejca.2022.04.033. Epub 2022 Jun 12. PubMed PMID: 35704975; PubMed Central PMCID: PMC10508975.
Jalal SI, Guo A, Ahmed S, Kelley MJ. Analysis of actionable genetic alterations in lung carcinoma from the VA National Precision Oncology Program. Semin Oncol. 2022 Jul 19;. doi: 10.1053/j.seminoncol.2022.06.014. [Epub ahead of print] PubMed PMID: 35902275.
Friedman DR, Halwani AS, Kelley MJ. Reply to B.L. King-Kallimanis et al. JCO Clin Cancer Inform. 2022 Jul;6:e2200075. doi: 10.1200/CCI.22.00075. PubMed PMID: 35878070.
Scott A, Mohan A, Austin S, Amini E, Raupp S, Pannecouk B, Kelley MJ, Narla G, Ramnath N. Integrating Medical Genetics Into Precision Oncology Practice in the Veterans Health Administration: The Time Is Now. JCO Oncol Pract. 2022 Jun;18(6):e966-e973. doi: 10.1200/OP.21.00693. Epub 2022 Mar 8. PubMed PMID: 35258993; PubMed Central PMCID: PMC9191304.
Price MJ, Vashistha V, Winski D, Kelley MJ, Bitting RL, Montgomery B. Homologous Recombination Repair Gene Variants and Outcomes Among Patients With Prostate Cancer Treated With Poly (ADP-ribose) Polymerase Inhibitors. JCO Precis Oncol. 2022 Apr;6(1):e2100461. doi: 10.1200/PO.21.00461. PubMed PMID: 35476551; PubMed Central PMCID: PMC9848572.
Dong OM, Poonnen PJ, Winski D, Reed SD, Vashistha V, Bates J, Kelley MJ, Voora D. Cost-Effectiveness of Tumor Genomic Profiling to Guide First-Line Targeted Therapy Selection in Patients With Metastatic Lung Adenocarcinoma. Value Health. 2022 Apr;25(4):582-594. doi: 10.1016/j.jval.2021.09.017. Epub 2021 Nov 1. PubMed PMID: 35365302; PubMed Central PMCID: PMC8976872.
Friedman DR, Patil V, Li C, Rassmussen KM, Burningham Z, Hamilton-Hill S, Kelley MJ, Halwani AS. Integration of Patient-Reported Outcome Measures in the Electronic Health Record: The Veterans Affairs Experience. JCO Clin Cancer Inform. 2022 Feb;6:e2100086. doi: 10.1200/CCI.21.00086. PubMed PMID: 35290072; PubMed Central PMCID: PMC8932492.
Sankar K, Bryant AK, Strohbehn GW, Zhao L, Elliott D, Moghanaki D, Kelley MJ, Ramnath N, Green MD. Real World Outcomes versus Clinical Trial Results of Durvalumab Maintenance in Veterans with Stage III Non-Small Cell Lung Cancer. Cancers (Basel). 2022 Jan 26;14(3). doi: 10.3390/cancers14030614. PubMed PMID: 35158881; PubMed Central PMCID: PMC8833364.
Dong OM, Roberts MC, Wu RR, Voils CI, Sperber N, Gavin KL, Bates J, Chanfreau-Coffinier C, Naglich M, Kelley MJ, Vassy JL, Sriram P, Heise CW, Rivas S, Ribeiro M, Chapman JG, Voora D. Evaluation of the Veterans Affairs Pharmacogenomic Testing for Veterans (PHASER) clinical program at initial test sites. Pharmacogenomics. 2021 Nov;22(17):1121-1133. doi: 10.2217/pgs-2021-0089. Epub 2021 Oct 27. PubMed PMID: 34704830; PubMed Central PMCID: PMC8592066.
O'Hanlon CE, Lindvall C, Giannitrapani KF, Garrido M, Ritchie C, Asch S, Gamboa RC, Canning M, Lorenz KA, Walling AM. Expert Stakeholder Prioritization of Process Quality Measures to Achieve Patient- and Family-Centered Palliative and End-of-Life Cancer Care. J Palliat Med. 2021 Sep;24(9):1321-1333. doi: 10.1089/jpm.2020.0633. Epub 2021 Feb 19. PubMed PMID: 33605800.
Hung A, Lee KM, Lynch JA, Li Y, Poonnen P, Efimova OV, Hintze BJ, Buckingham T, Yong C, Seal B, Kelley MJ, Reed SD. Chemoradiation treatment patterns among United States Veteran Health Administration patients with unresectable stage III non-small cell lung cancer. BMC Cancer. 2021 Jul 16;21(1):824. doi: 10.1186/s12885-021-08577-y. PubMed PMID: 34271861; PubMed Central PMCID: PMC8285779.
Vashistha V, Armstrong J, Winski D, Poonnen PJ, Hintze B, Price M, Snowdon JL, Weeraratne D, Brotman D, Jackson GP, Kelley MJ. Barriers to Prescribing Targeted Therapies for Patients With NSCLC With Highly Actionable Gene Variants in the Veterans Affairs National Precision Oncology Program. JCO Oncol Pract. 2021 Jul;17(7):e1012-e1020. doi: 10.1200/OP.20.00703. Epub 2021 Mar 29. PubMed PMID: 33780286.
Jazowski SA, Sico IP, Lindquist JH, Smith VA, Bosworth HB, Danus S, Provenzale D, Kelley MJ, Zullig LL. Transportation as a barrier to colorectal cancer care. BMC Health Serv Res. 2021 Apr 13;21(1):332. doi: 10.1186/s12913-021-06339-x. PubMed PMID: 33849524; PubMed Central PMCID: PMC8045363.
Becker DJ, Lee KM, Lee SY, Lynch KE, Makarov DV, Sherman SE, Morrissey CD, Kelley MJ, Lynch JA. Uptake of KRAS Testing and Anti-EGFR Antibody Use for Colorectal Cancer in the VA. JCO Precis Oncol. 2021;5. doi: 10.1200/PO.20.00359. eCollection 2021. PubMed PMID: 34250412; PubMed Central PMCID: PMC8232805.
Dong OM, Bates J, Chanfreau-Coffinier C, Naglich M, Kelley MJ, Meyer LJ, Icardi M, Vassy JL, Sriram P, Heise CW, Rivas S, Ribeiro M, Jacobitz R, Rozelle S, Chapman JG, Voora D. Veterans Affairs Pharmacogenomic Testing for Veterans (PHASER) clinical program. Pharmacogenomics. 2021 Feb;22(3):137-144. doi: 10.2217/pgs-2020-0173. Epub 2021 Jan 6. PubMed PMID: 33403869.
Hung A, Lee KM, Alba PR, Li Y, Gao AZ, Hintze BJ, Efimova OV, Shenolikar R, Pavilack M, Simmons D, Kelley MJ, Lynch JA, Reed SD. EGFR mutation testing and TKI treatment patterns among veterans with stage III and IV non-small cell lung cancer. Cancer Treat Res Commun. 2021;27:100327. doi: 10.1016/j.ctarc.2021.100327. Epub 2021 Jan 29. PubMed PMID: 33549984.
Walhart, T, Weissman, B, Yip, S, Alcorta, D, Kelley, M. TARGETING SMARCBi IN PEDIATRIC CHORDOMA DEVELOPMENT. Oncology Nursing Forum; 2021 Mar; c2021.
Kelley MJ. VA National Precision Oncology Program. Fed Pract. 2020 Aug;37(Suppl 4):S22-S27. doi: 10.12788/fp.0037. PubMed PMID: 32908351; PubMed Central PMCID: PMC7473726.
Vashistha V, Poonnen PJ, Snowdon JL, Skinner HG, McCaffrey V, Spector NL, Hintze B, Duffy JE, Weeraratne D, Jackson GP, Kelley MJ, Patel VL. Medical oncologists' perspectives of the Veterans Affairs National Precision Oncology Program. PLoS One. 2020;15(7):e0235861. doi: 10.1371/journal.pone.0235861. eCollection 2020. PubMed PMID: 32706774; PubMed Central PMCID: PMC7380614.
Chapman M, Williams C, Redding T, Bartlett R, Chawla N, Provenzale D, Kelley M. Abstract PR11: Racial differences in characteristics of early- vs. late-onset colorectal cancer among veterans. Oral Presentations - Proffered Abstracts. Abstracts: Eleventh AACR Conference on The Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; November 2-5, 2018; New Orleans, LA; ; American Association for Cancer Research; c2020.
Katsoulakis E, Duffy JE, Hintze B, Spector NL, Kelley MJ. Comparison of Annotation Services for Next-Generation Sequencing in a Large-Scale Precision Oncology Program. JCO Precis Oncol. 2020;4. doi: 10.1200/PO.19.00118. eCollection 2020. PubMed PMID: 32923873; PubMed Central PMCID: PMC7446349.
Williams CD, Alpert N, Redding TS 4th, Bullard AJ, Flores RM, Kelley MJ, Taioli E. Racial Differences in Treatment and Survival among Veterans and Non-Veterans with Stage I NSCLC: An Evaluation of Veterans Affairs and SEER-Medicare Populations. Cancer Epidemiol Biomarkers Prev. 2020 Jan;29(1):112-118. doi: 10.1158/1055-9965.EPI-19-0245. Epub 2019 Oct 17. PubMed PMID: 31624076.
Spiegel DY, Boyer MJ, Hong JC, Williams CD, Kelley MJ, Salama JK, Palta M. Survival Advantage With Adjuvant Chemotherapy for Locoregionally Advanced Rectal Cancer: A Veterans Health Administration Analysis. J Natl Compr Canc Netw. 2020 Jan;18(1):52-58. doi: 10.6004/jnccn.2019.7329. PubMed PMID: 31910388.
Chapman, M, Williams, CD, Redding, TI, Bartlett, R, Chawla, N, Provenzale, D, Kelley, MJ. Racial differences in characteristics of early- vs. late-onset colorectal cancer among veterans. Cancer Epidemiology, Biomarkers and Prevention; 2020 Jun; c2020.
Williams, CD, Gu, L, Vashistha, V, Press, A, Kelley, MJ. Comparison of characteristics and outcomes among veterans receiving first-line immunotherapy versus chemotherapy for stage IV non-small cell lung cancer. Journal of Clinical Oncology; 2020 May; c2020.
Poonnen, P, Dong, O, Winski, D, Reed, SD, Vashistha, V, Bates, JS, Kelley, MJ, Voora, D. Cost-effectiveness of genomic profiling in veterans with metastatic lung adenocarcinoma. Journal of Clinical Oncology; 2020 May; c2020.
Zullig LL, Jazowski SA, Chawla N, Williams CD, Winski D, Slatore CG, Clary A, Rasmussen KM, Ticknor LM, Kelley MJ. Summary of Veterans Health Administration Cancer Data Sources. J Registry Manag. 2019 Fall;46(3):76-83. PubMed PMID: 35364675.
Lynch J, Kelley M, Lee K, Hung A, Li Y, Hintze B, Pendergraft T, Pavilack M, Efimova O, DuVall S, Reed S. An NLP tool to identify molecular diagnostic testing in veterans with stage IV NSCLC. Journal of Clinical Oncology. 2019 September; 37(27_suppl):318-318. doi: 10.1200/JCO.2019.37.27_suppl.318.
Poonnen PJ, Duffy JE, Hintze B, Shukla M, Brettin TS, Conrad NR, Yoo H, Guertin C, Looney JA, Vashistha V, Kelley MJ, Spector NL. Genomic Analysis of Metastatic Solid Tumors in Veterans: Findings From the VHA National Precision Oncology Program. JCO Precis Oncol. 2019;3. doi: 10.1200/PO.19.00075. eCollection 2019. PubMed PMID: 32914016; PubMed Central PMCID: PMC7446382.
Bates SE, Kelley MJ. VA Cancer Research: A Legacy and A Future. Semin Oncol. 2019 Aug-Oct;46(4-5):305-307. doi: 10.1053/j.seminoncol.2019.11.001. PubMed PMID: 31818371.
Zullig LL, Smith VA, Lindquist JH, Williams CD, Weinberger M, Provenzale D, Jackson GL, Kelley MJ, Danus S, Bosworth HB. Cardiovascular disease-related chronic conditions among Veterans Affairs nonmetastatic colorectal cancer survivors: a matched case-control analysis. Cancer Manag Res. 2019;11:6793-6802. doi: 10.2147/CMAR.S191040. eCollection 2019. PubMed PMID: 31413631; PubMed Central PMCID: PMC6659791.
What would you like to do?